Oncology (Williston Park, N.Y.) · 2020
Challenges of Treating a Patient With Advanced Prostate Cancer During the COVID-19 Pandemic.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Carril-Ajuria Lucil, Remolina-Bonilla Yuly A, Carretero-Gonzalez Alberto, Martin-Soberon Maricruz, Castellano Daniel, Bourlon Christianne, de Velasco Guillermo, Bourlon Maria T
Аннотация
A 78-year-old man had a medical history of hypertension, atrial fibrillation, chronic kidney disease, and metastatic castration-resistant prostate cancer (CRPC). He had progressed to first-line therapy for CRPC with abiraterone plus androgen-deprivation therapy (ADT) and as second-line therapy he was being treated with docetaxel, with biochemical progression in his last prostate specific antigen measurement. He was admitted to the hospital on April 2020, in the middle of the coronavirus disease 2019 (COVID-19) pandemic, because of painful bone lesions and deterioration of renal function.
Предметные рубрики MeSH
AgedAndrogen AntagonistsAndrostenesAnticoagulantsAntineoplastic AgentsBetacoronavirusBone Density Conservation AgentsBone NeoplasmsCOVID-19Cancer PainCoronavirus InfectionsDisease ProgressionDocetaxelDrug CombinationsEligibility DeterminationHeparin, Low-Molecular-WeightHumansIntensive Care UnitsLopinavirMaleOxygen Inhalation TherapyPalliative CarePandemicsPneumonia, ViralProstatic Neoplasms, Castration-ResistantRenal InsufficiencyRespiratory InsufficiencyReverse Transcriptase Polymerase Chain ReactionRitonavirSARS-CoV-2Severity of Illness IndexZoledronic Acid